King & Spalding and Latham & Watkins hired partners focused on the pharmaceutical industry on Monday, growing their presence in one of the few legal practices predicted to grow this year.
King & Spalding hired Eva Temkin from the U.S. Food and Drug Administration, where she most recently served as acting director for policy at the Office of Therapeutic Biologics and Biosimilars. Temkin will be a Washington-based partner in the Atlanta-founded firm’s FDA and life sciences practice.
Latham, meanwhile, hired Christopher Schott to its healthcare and life sciences practice in its Washington office. Schott joined from Hogan Lovells, where he ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.